Antitumor agent-75

• Description:

  Antitumor agent-75 is a novel potent antitumor agent. Antitumor agent-75 has cytotoxic effects on cancer and normal human cell lines. Antitumor agent-75 shows a highly selective cytotoxic effect against human lung adenocarcinoma (cell line A549) when combined with Antitumor agent-74 (HY-151292), the IC50 value of 2.8 μM. Antitumor agent-75 can be used for the research of cancer[1].

• UNSPSC:

  12352005

• Target:

  DNA/RNA Synthesis

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/antitumor-agent-75.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CN1CCN (C2=CC=C3N=C (C4=NC5=CC=CC=C5N4) C (C6=CC=C (F) C=C6) =NC3=C2) CC1

• Molecular Formula:

  C26H23FN6

• Molecular Weight:

  438.50

• References & Citations:

  [1]Vakhid A. Mamedov, et al. Synthesis of Morpholine‑, Piperidine‑, and N‑Substituted Piperazine-Coupled 2‑ (Benzimidazol-2-yl) -3-arylquinoxalines as

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  2827065-29-0